Weihua Xiao

5.5k total citations · 1 hit paper
82 papers, 3.9k citations indexed

About

Weihua Xiao is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Weihua Xiao has authored 82 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Immunology, 39 papers in Oncology and 33 papers in Molecular Biology. Recurrent topics in Weihua Xiao's work include Immune Cell Function and Interaction (31 papers), Cytokine Signaling Pathways and Interactions (17 papers) and T-cell and B-cell Immunology (16 papers). Weihua Xiao is often cited by papers focused on Immune Cell Function and Interaction (31 papers), Cytokine Signaling Pathways and Interactions (17 papers) and T-cell and B-cell Immunology (16 papers). Weihua Xiao collaborates with scholars based in China, United States and France. Weihua Xiao's co-authors include Zhigang Tian, Rui Sun, Dhananjaya V. Kalvakolanu, Cheng Sun, Haoyu Sun, Yongyan Chen, Min Cheng, Fang Fang, Haiming Wei and Venkatadri Kolla and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Weihua Xiao

82 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NK cell-based immunotherapy for malignant diseases

2013 507 citations Min Cheng, Weihua Xiao et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Weihua Xiao China	36	2.4k	1.7k	1.3k	489	251	82	3.9k
Gang Zhou United States	34	2.9k 1.2×	2.1k 1.2×	1.1k 0.8×	504 1.0×	264 1.1×	71	4.6k
Matteo Bellone Italy	36	2.6k 1.1×	1.6k 1.0×	1.8k 1.4×	604 1.2×	210 0.8×	110	4.6k
Masoud H. Manjili United States	35	2.6k 1.1×	2.2k 1.3×	1.7k 1.4×	561 1.1×	354 1.4×	124	4.7k
Stephan Gasser Singapore	29	3.2k 1.3×	1.4k 0.9×	1.3k 1.1×	281 0.6×	436 1.7×	50	4.4k
Mary M. Tomayko United States	21	1.8k 0.8×	1.0k 0.6×	1.2k 0.9×	389 0.8×	259 1.0×	41	4.0k
Mikael C. I. Karlsson Sweden	39	3.4k 1.4×	1.1k 0.7×	1.9k 1.5×	593 1.2×	295 1.2×	104	5.4k
Todd D. Schell United States	31	1.8k 0.8×	1.5k 0.9×	785 0.6×	222 0.5×	248 1.0×	97	3.1k
Réjean Lapointe Canada	30	2.1k 0.9×	1.2k 0.7×	1.0k 0.8×	221 0.5×	372 1.5×	80	4.0k
Thomas Welte United States	33	1.5k 0.6×	1.7k 1.0×	1.5k 1.2×	595 1.2×	183 0.7×	65	4.0k

Countries citing papers authored by Weihua Xiao

Since Specialization

Citations

This map shows the geographic impact of Weihua Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weihua Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weihua Xiao more than expected).

Fields of papers citing papers by Weihua Xiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weihua Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weihua Xiao. The network helps show where Weihua Xiao may publish in the future.

Co-authorship network of co-authors of Weihua Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Weihua Xiao. A scholar is included among the top collaborators of Weihua Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weihua Xiao. Weihua Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Lin, Dabao Wu, Zhen Shen, et al.. (2023). Clinical safety and efficacy observation of ex vivo-expanded peripheral blood-derived allogeneic NK cells in the treatment of refractory or recurrent ovarian cancer.. Journal of Clinical Oncology. 41(16_suppl). e17553–e17553. 1 indexed citations

Chen, Shuangfeng, et al.. (2021). A Review of the Clinical Characteristics and Novel Molecular Subtypes of Endometrioid Ovarian Cancer. Frontiers in Oncology. 11. 668151–668151. 25 indexed citations

Zhu, Chenchen, Jing Zhu, Lili Qian, et al.. (2021). Clinical characteristics and prognosis of ovarian clear cell carcinoma: a 10-year retrospective study. BMC Cancer. 21(1). 322–322. 34 indexed citations

Miao, Yuhui, et al.. (2020). BCAP Regulates Dendritic Cell Maturation Through the Dual-Regulation of NF-κB and PI3K/AKT Signaling During Infection. Frontiers in Immunology. 11. 250–250. 14 indexed citations

Sun, Haoyu, Lianxin Liu, Qiang Huang, et al.. (2019). Accumulation of Tumor-Infiltrating CD49a+ NK Cells Correlates with Poor Prognosis for Human Hepatocellular Carcinoma. Cancer Immunology Research. 7(9). 1535–1546. 72 indexed citations

Fang, Fang, Wei Wang, Minhua Chen, Zhigang Tian, & Weihua Xiao. (2019). Technical advances in NK cell-based cellular immunotherapy. Cancer Biology and Medicine. 16(4). 647–654. 23 indexed citations

Sun, Haoyu, Jing Xu, Qiang Huang, et al.. (2018). Reduced CD160 Expression Contributes to Impaired NK-cell Function and Poor Clinical Outcomes in Patients with HCC. Cancer Research. 78(23). 6581–6593. 42 indexed citations

Zhou, Ying, Fei Xu, Tao Feng, et al.. (2016). GRIM-19 Restores Cervical Cancer Cell Senescence by Repressing hTERT Transcription. Journal of Interferon & Cytokine Research. 36(8). 506–515. 3 indexed citations

Guo, Yugang, Changsheng Shao, Jing Wu, et al.. (2016). Elimination of N-glycosylation by site mutation further prolongs the half-life of IFN-α/Fc fusion proteins expressed in Pichia pastoris. Microbial Cell Factories. 15(1). 209–209. 8 indexed citations

10.

Wu, Huimei, Zi‐Feng Jiang, Tong Wang, et al.. (2014). Reversed expression of GRIM-1 and GRP78 in human non–small cell lung cancer. Human Pathology. 45(9). 1936–1943. 10 indexed citations

11.

Hu, Xiaoli, Yanfang Jiang, Xiurong Li, et al.. (2013). Long-Term Effect on Natural Killer Cells by Interferon-α Therapy on the Outcomes of HCV Infection. Journal of Interferon & Cytokine Research. 34(5). 366–375. 6 indexed citations

12.

Fang, Fang, Yan Wang, Rui Li, et al.. (2012). Transcription factor E2F1 suppresses dendritic cell maturation. (167.3). The Journal of Immunology. 188(1_Supplement). 167.3–167.3. 2 indexed citations

13.

Zhang, Xulong, Weihua Xiao, Lihua Wang, Zhigang Tian, & Jian Zhang. (2011). Deactivation of Signal Transducer and Activator of Transcription 3 Reverses Chemotherapeutics Resistance of Leukemia Cells via Down-Regulating P-gp. PLoS ONE. 6(6). e20965–e20965. 58 indexed citations

14.

Wang, Yan, Rui Li, Ying Zhao, et al.. (2010). Transcription Factor E2F1 Suppresses Dendritic Cell Maturation. The Journal of Immunology. 184(11). 6084–6091. 37 indexed citations

15.

Shen, Guodong, Anli Zhang, Ting Zhao, et al.. (2010). In vivo activity of novel anti-ErbB2 antibody chA21 alone and with Paclitaxel or Trastuzumab in breast and ovarian cancer xenograft models. Cancer Immunology Immunotherapy. 60(3). 339–348. 16 indexed citations

16.

Zhou, Ying, Min Li, Wei Ying, et al.. (2009). Down-Regulation of GRIM-19 Expression Is Associated With Hyperactivation of STAT3-Induced Gene Expression and Tumor Growth in Human Cervical Cancers. Journal of Interferon & Cytokine Research. 29(10). 695–704. 38 indexed citations

17.

Xiao, Weihua, David R. Hodge, Lihua Wang, et al.. (2004). Co‐operative functions between nuclear factors NFκB and CCAT/enhancer‐binding protein‐β (C/EBP‐β) regulate the IL‐6 promoter in autocrine human prostate cancer cells. The Prostate. 61(4). 354–370. 78 indexed citations

18.

Li, Xiaoling, John A. Blackford, Mingjuan Liu, et al.. (2000). RNase-L-dependent Destabilization of Interferon-induced mRNAs. Journal of Biological Chemistry. 275(12). 8880–8888. 103 indexed citations

19.

Xiao, Weihua, Venkatadri Kolla, & Dhananjaya V. Kalvakolanu. (1997). Modulation of Interferon Action by Retinoids. Journal of Biological Chemistry. 272(15). 9742–9748. 73 indexed citations

20.

Kolla, Venkatadri, Daniel J. Lindner, Weihua Xiao, Ernest C. Borden, & Dhananjaya V. Kalvakolanu. (1996). Modulation of Interferon (IFN)-inducible Gene Expression by Retinoic Acid. Journal of Biological Chemistry. 271(18). 10508–10514. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact